glp-1 drugs mechanism of action and Anesthesia: Considerations and Cautions for CRNAs Discovery of GLP-1–Based Drugs for

*Correspondence: Lrke Smidt Gasbjerg, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

One of the reasons for its success was because it provided better control of blood glucose levels than previous treatments

Glucagon-like peptide-1 (GLP-1) receptor agonists are medications approved by the FDA for managing type 2 diabetes and, in some formulations, for chronic weight management

review notes that gastrointestinal adverse events are the most frequently reported side effects across the pediatric trials [1]

The hormonal changes observed in our analysis further contribute to the therapeutic potential of GLP-1RAs, though the impact was less consistent compared to their effects on anthropometric measurements and glucose regulation

The practice of microdosing GLP-1 medications is mainly experimental and off-label